Back to top
more

Phibro Animal Health (PAHC)

(Real Time Quote from BATS)

$12.42 USD

12.42
40,705

-0.14 (-1.12%)

Updated Apr 25, 2024 01:32 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (150 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for PAHC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Phibro Animal Health Corporation falls in the month of June.

All items in Millions except Per Share data.

6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019
Assets          
Cash & Equivalents 81 91 93 91 82
Receivables 163 167 147 127 159
Notes Receivable 0 0 0 0 0
Inventories 278 259 216 197 198
Other Current Assets 63 49 43 37 27
Total Current Assets 586 566 499 452 466
Net Property & Equipment 196 165 155 148 140
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 108 117 115 124 75
Deposits & Other Assets 82 83 73 60 45
Total Assets 971 932 841 784 727
Liabilities & Shareholders Equity 6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019
Notes Payable 0 0 0 0 0
Accounts Payable 74 96 68 66 73
Current Portion Long-Term Debt 22 15 9 19 13
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 80 80 86 72 69
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 176 191 164 157 154
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 453 418 383 368 314
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 60 61 56 70 43
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 689 669 603 596 511
Shareholders Equity 6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 136 136 136 136 133
Retained Earnings 261 248 218 183 169
Other Equity -114 -121 -115 -130 -86
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 283 262 239 188 216
Total Liabilities & Shareholder's Equity 971 932 841 784 727
Total Common Equity 283 262 239 188 216
Shares Outstanding 40.50 40.50 40.50 40.40 40.40
Book Value Per Share 6.98 6.48 5.89 4.66 5.35

Fiscal Year End for Phibro Animal Health Corporation falls in the month of June.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 92 91 81 77
Receivables NA 151 149 163 153
Notes Receivable NA 0 0 0 0
Inventories NA 287 279 278 293
Other Current Assets NA 57 65 63 63
Total Current Assets NA 587 584 586 585
Net Property & Equipment NA 201 193 196 189
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 106 105 108 110
Deposits & Other Assets NA 80 81 82 81
Total Assets NA 973 965 971 965
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 86 77 74 76
Current Portion Long-Term Debt NA 26 24 22 15
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 75 71 80 74
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 188 172 176 165
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 449 459 453 466
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 60 60 62
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 702 691 689 693
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 136 136 136 136
Retained Earnings NA 244 248 261 254
Other Equity NA -110 -111 -114 -118
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 271 273 283 272
Total Liabilities & Shareholder's Equity NA 973 965 971 965
Total Common Equity 0 271 273 283 272
Shares Outstanding 40.50 40.50 40.50 40.50 40.50
Book Value Per Share 0.00 6.69 6.74 6.98 6.72